The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
Authors:
- 9 November 2012
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 77 (6) , 791-801
Abstract
Summary: Polycystic ovary syndrome (PCOS) is a common endocrine condition associated with long‐term health risks, including type 2 diabetes and vascular dysfunction in addition to reproductive sequelae. Many of the common features of PCOS, such as central obesity, hyperinsulinaemia and obstructive sleep apnoea (OSA), are associated with chronic sympathetic overactivity, suggesting that sympathoexcitation may be involved in the pathogenesis of this condition. Rodent models of polycystic ovaries have shown that ovarian sympathetic outflow may be increased, accompanied by elevated intra‐ovarian synthesis of nerve growth factor (NGF) which may be involved in initiation of ovarian pathology. Patients with PCOS have evidence of increased muscle sympathetic nerve activity (MSNA), altered heart rate variability and attenuated heart rate recovery postexercise, compared with age‐ and BMI‐matched controls, suggesting a generalized increase in sympathetic nerve activity. Active weight loss can reduce MSNA and whole body noradrenaline spillover, whereas low‐frequency electroacupuncture decreased MSNA in overweight women with PCOS. Treatment of OSA with continuous positive airways pressure may reduce plasma noradrenaline levels and diastolic blood pressure and improve cardiac sympathovagal balance. Renal sympathetic denervation also reduced MSNA, noradrenaline spillover and blood pressure in two PCOS subjects with hypertension, accompanied by improved insulin sensitivity. The sympathetic nervous system may thus offer a new therapeutic target in PCOS but larger and longer‐term studies are needed before these treatments can be considered in clinical practice.Keywords
This publication has 90 references indexed in Scilit:
- Obesity and adipokines: effects on sympathetic overactivityThe Journal of Physiology, 2012
- Arcuate nucleus – a gateway for insulin's action on sympathetic activityThe Journal of Physiology, 2011
- Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in ratsThe Journal of Physiology, 2011
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2011
- Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trialAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- CRTC3 links catecholamine signalling to energy balanceNature, 2010
- Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humansThe Journal of Physiology, 2010
- Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in HumansEndocrinology, 2009
- Leptin Signaling in the Nucleus Tractus Solitarii Increases Sympathetic Nerve Activity to the KidneyHypertension, 2009
- Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008